Patient active studies | FOMAT

With FOMAT, you can join clinical trials to better understand your condition, help advance medicine, and receive study-related care at no cost. Many studies also offer compensation for your time.

NSCLC

A study exploring a possible treatment option for adults with advanced non-small cell lung cancer.

Criteria & Qualifications:

Are 18 years of age or older
Have advanced non small cell lung cancer
Need another treatment option after earlier treatment

Compensation: Contact Us for more info

Heart Failure With Preserved Ejection Fraction

A study exploring a possible treatment option for adults with heart failure and preserved ejection fraction.

Criteria & Qualifications:

Are 50 years of age or older
Have heart failure with preserved ejection fraction
Have ongoing heart failure symptoms

Compensation: Contact Us for more info

Colorectal Cancer

A study exploring a possible treatment to help support weight and muscle during chemotherapy.

Criteria & Qualifications:

Are 18 years of age or older
Have newly diagnosed metastatic colorectal cancer
Are preparing to start chemotherapy

Compensation: Contact Us for more info

Advanced Solid Tumor

A study evaluating a possible new treatment for people with cold-triggered hives or skin reactions.

Criteria & Qualifications:

Are 18 years of age or older
Have an advanced solid tumor
Have cancer that can be measured on scans

Compensation: Contact Us for more info

Hormone-Positive Breast Cancer Study

A study exploring a possible treatment option for people with advanced breast cancer.

Criteria & Qualifications:

Are over 18 years old
Have HR positive, HER2-negative breast cancer
Have advanced or metastatic disease

Compensation: Contact Us for more info

Newborn Pneumococcal Vaccine Study

A study evaluating the safety of a possible new vaccine option for healthy infants.

Criteria & Qualifications:

Are 42 to 89 days old
Are healthy based on medical evaluation
Were born full term, or were born medically stable and meet the study’s birth requirements

Compensation: Contact Us for more info

Foot and Leg Ulcer Study

This study is evaluating new treatment options for hard-to-heal diabetic foot ulcers and venous leg ulcers.

Criteria & Qualifications:

Are 18 years of age or older
Have a foot or leg wound that has been difficult to heal for several weeks
Have not seen enough improvement with the care or treatment you are currently receiving

Compensation: Contact Us for more info

MASH Liver Scarring Study

A study exploring a possible new treatment for adults living with MASH and liver scarring.

Criteria & Qualifications:

Are 18 or older
Are living with obesity and have a liver condition called MASH or NASH
May have moderate to advanced liver scarring

Compensation: Contact Us for more info

MASH Study

A study exploring a possible new treatment for adults living with NASH or MASH.

Criteria & Qualifications:

Are 18 or older
Have been told you have MASH or NASH
Are living with overweight or obesity

Compensation: Contact Us for more info

Obesity

A study exploring a possible new treatment for adults living with obesity.

Criteria & Qualifications:

Are between 18 and 65 years of age
Are living with obesity
Do not have diabetes

Compensation: Contact us for more information

(805) 465-3574
[email protected]

Find a trial

By submitting this form, you acknowledge and agree that FOMAT Medical Research may collect, use, and process your personal and/or health information in accordance with its Privacy Policy. You also consent to receiving communications from FOMAT Medical Research and understand that we may contact you regarding relevant information and opportunities.

Clinical trials are research studies designed to evaluate the safety, effectiveness, and outcomes of medical treatments, devices, or interventions in human participants. They follow structured protocols that help researchers collect reliable data, assess results, and ensure patient safety and ethical compliance.

There are different types of clinical trials, ranging from early-phase studies focused on safety and dosage to late-phase trials that evaluate effectiveness across larger populations. Each phase plays a critical role in advancing medical knowledge and bringing new therapies to patients.